Open Journal of Asthma

Journal Information
EISSN: 26408082
Total articles ≅ 18

Latest articles in this journal

Altamirano Gustavo Acosta, Rodríguez Carlos E Miguel, Reyes-Montes María del Rocío, Duarte-Escalante Esperanza, Acosta-Reyes Rocío, Torres-Estrella Carlos U, Valencia-Ledezma Omar E
Published: 29 October 2022
Open Journal of Asthma, Volume 6, pp 008-017;

At the end of 2019, in Wuhan, China, an outbreak of cases of respiratory tract infection emerged and its progressive infection mainly affects adults, generating many cases of pneumonia. A type of coronavirus named SARS-CoV-2, with genomic similarity to SARS-CoV and MERS-CoV, was identified as the etiological agent. The evolution of this pandemic has made it possible to verify the similarity in the pathophysiological mechanisms between these three viruses, identifying the Angiotensin-Converting protein-Enzyme 2 (ACE2) as the primary receptor for SARS-CoV-2. This age group is more prone to developing extrapulmonary complications from SARS-CoV-2 since the clinical and pathological findings suggest a particular relationship between greater expression of ACE2 and the comorbidities of chronic degenerative diseases and the greater expression of ACE2 at the level of the respiratory tract. It has also revealed the mechanisms by which the virus evades the innate immune response and the Th1-type adaptive response. The objective of this work was to analyze immunosenescence and its relationship with SARS-CoV-2 infection, through the review of the most recent articles (2021-2022), which describes the senescent state of the elderly. In addition, it intends to highlight the probable causes for which the most vulnerable population group (adults over 60 years of age) is more prone to presenting complications during the infection.
Armeftis Charis, Lemessios Marinos, Anastasiades Christos, Gratziou Christina, Siafakas Nikolaos, Katsaounou Paraskevi, Bakakos Petros
Published: 28 September 2022
Open Journal of Asthma, Volume 6, pp 001-007;

Background: Although asthma is a common disease accurate diagnosis is missing and it has been reported that often it is over or under-diagnosed. Aim: To investigate if a physician’s diagnosis of asthma in Cyprus is correct by using a structured algorithm at the outpatient primary care level. Subjects and Methods: Sixty adults with a self-reported physician diagnosis of asthma, mean age of 47,8 years (29 males and 31 females) were included in the study. Medical history and physical examination, pre-post bronchodilation spirometry and methacholine bronchial challenge test was used to confirm or rule out the diagnosis as well as a three months follow-up. In addition, the cost of treatment was estimated. Results: Sixteen subjects (27%) had a positive pre-post bronchodilation spirometric test and were considered asthmatics. In 9 out of the 44 remaining subjects a positive Methacholine provocation test confirmed the diagnosis of asthma. The rest of the subjects (n = 35) went into a 3 months observational period during which only 2 showed asthmatic symptoms and were considered asthmatics by a second methacholine test that confirmed the diagnosis. Therefore, a correct asthma diagnosis was established in only 27(45%) of subjects. The annual average cost of medication for asthma confirmed the group was 313 euro/patient (171-454, 95% CI) and the average 2-year unnecessary (asthma ruled-out group) cost of treatment was approximately 297 euro/patient. (179-415, 95% CI). Conclusions: Physician-diagnosed asthma overestimates the actual prevalence of disease in adults in Cyprus since it was shown that more than half of the participants did not have Asthma. These individuals consume unneeded medications at a significant cost. Thus, the correct diagnosis of Asthma should be made by using more specific tests starting at the primary care level.
Nasab Entezar Mehrabi, Athari Seyyed Shamsadin
Published: 24 August 2021
Open Journal of Asthma, Volume 5, pp 009-110;

Cedrone Maria Civita, Marino Luca, Suppa Marianna,
Open Journal of Asthma, Volume 5, pp 007-008;

Through stern social restraint measures, Italy has recently overcome the epidemic peak of COVID-19 (Coronavirus Disease-19) respiratory syndrome induced by SARS-CoV-2 and the attention is progressively moving toward its sequelae, especially on pulmonary fibrosis and the associated pulmonary functional decline [1-3].
, Ioannou Marios, Hyland Michael E, Odemyr Mikaela, Spranger Otto, Lindberg Anne, Gasser Matthias, Conde Lorena Garcia, Jaumont Xavier, Kasujee Ismail
Published: 9 December 2019
Open Journal of Asthma, Volume 3, pp 001-008;

Back to Top Top